Phenotypic Assays

Assays that quantify disease phenotype changes in cells require no a prior knowledge of disease mechanism of action. A good example of this is in the field of oncology, where uncontrolled cell proliferation is a hallmark of cancer and can be used as the basis for a phenotypic assay. Cytation™ and Lionheart™ can quantify many types of phenotype change, such as counting cells by either fluorescence or brightfield microscopy in the case of cell proliferation. Many other phenotypes can be quantified based on the use of specific fluorescent probes, such as those for oxidative stress, hypoxia, apoptosis, translocation, etc and the image analysis capabilities of Gen5™ Image Prime that provide dual masking capabilities and sub-population analyses based on a wide range of calculated metrics.

 MDA-MB-231-cells-at-20x-0-Hours
MDA-MB-231-cells-at-20x-6-Hours
MDA-MB-231-cells-at-20x-24-Hours

Phase contrast monitoring of MDA-MB-231 cells undergoing oridonin-induced apoptosis at 0, 6 and 20 hrs.

 

Application Notes:

 

Visual Abstracts (.mp4):

BioTek’s Visual Abstracts are brief animated presentations describing the Augmented Microscopy workflow of a specific application.

link

Utilizamos cookies para proporcionar a los visitantes de nuestro sitio web, la mejor experiencia posible. Si continúa sin cambiar la configuración de su navegador, asumiremos que está de acuerdo en recibir todas las cookies del sitio web de BioTek. Para obtener más información sobre cómo utilizamos las cookies o cómo bloquear las cookies,  visite nuestra sección de política de cookies.